NasdaqGS - Nasdaq Real Time Price USD
AbCellera Biologics Inc. (ABCL)
2.5598
+0.0298
+(1.18%)
As of 9:51:24 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 68.19M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.16 per share. | Direct | 742,243 | Mar 11, 2025 |
| MONTALBANO JOHN S. Director | Purchase at price 2.30 per share. | Direct | 57,500 | Mar 10, 2025 |
| MONTALBANO JOHN S. Director | Purchase at price 2.34 per share. | Direct | 140,568 | Mar 6, 2025 |
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | Nov 25, 2024 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | Sep 20, 2024 |
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.61 per share. | Direct | 739,977 | Aug 29, 2024 |
| LECAULT VERONIQUE Chief Operating Officer | Conversion of Exercise of derivative security at price 0.19 per share. | Direct | 15,667 | Jun 21, 2024 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | May 31, 2024 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | Feb 26, 2024 |
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 19, 2023 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | Nov 22, 2023 |
| MONTALBANO JOHN S. Director | Purchase at price 4.46 - 4.64 per share. | Direct | 137,400 | Nov 8, 2023 |
| HAYDEN MICHAEL REUBEN Director | Purchase at price 4.91 per share. | Indirect | 98,200 | Sep 22, 2023 |
| LECAULT VERONIQUE Chief Operating Officer | Purchase at price 5.19 per share. | Direct | 103,800 | Sep 12, 2023 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | Aug 24, 2023 |
| HAYDEN MICHAEL REUBEN Director | Purchase at price 5.90 per share. | Indirect | 177,000 | Aug 8, 2023 |
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.52 per share. | Direct | 997,728 | May 26, 2023 |
| BOOTH ANDREW Chief Financial Officer | Purchase at price 6.85 per share. | Direct | 99,325 | May 26, 2023 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.70 per share. | Direct | 151,538 | May 26, 2023 |
| LECAULT VERONIQUE Chief Operating Officer | Conversion of Exercise of derivative security at price 0.19 per share. | Direct | 47,500 | May 5, 2023 |
Related Tickers
ABSI Absci Corporation
3.1950
+0.16%
NTLA Intellia Therapeutics, Inc.
8.14
+0.56%
RLAY Relay Therapeutics, Inc.
3.0600
-1.61%
ADPT Adaptive Biotechnologies Corporation
7.41
+0.34%
EDIT Editas Medicine, Inc.
1.5350
-1.60%
CRBU Caribou Biosciences, Inc.
0.8464
+0.49%
RXRX Recursion Pharmaceuticals, Inc.
5.69
+1.88%
PRME Prime Medicine, Inc.
1.7550
-1.40%
BEAM Beam Therapeutics Inc.
19.75
-0.60%
VERV Verve Therapeutics, Inc.
5.68
+3.84%